Dr. Kurth is a Director of Research at the French National Institute of Health and Medical Research Institut national de la santé et de la recherche médicale (Inserm), Research Center for Epidemiolgy and Biostatistics (U897) – Team Neuroepidemiology, Bordeaux, France. He is Adjunct Professor of Epidemiology at the Harvard School of Public Health, as well as Lecturer in Medicine at Harvard Medical School. He is further Associate Epidemiologist and Co-Director of neuroepidemiology in the Division of Preventive Medicine, Brigham and Women’s Hospital in Boston, MA. Dr. Kurth is a Fellow of the American Academy of Neurology (FAAN) and member of the board of trustees at the International Headache Society.
Tobias Kurth received his M.D. from the University of Tübingen in Germany and a doctorate in epidemiology from the Harvard School of Public Health. He served as a resident in the Department of Neurology at the University Hospital of Essen, Germany, which has a strong focus on migraine headache and stroke.
Dr. Kurth has published >200 articles in indexed journals and is ranked among the top 1% of scientists by the ISI Web of Science in the field clinical medicine. He is Associate Editor of Cephalalgia and Consulting Clinical Epidemiology Editor at the BMJ. He is involved in teaching and training in France, the United States, and Germany, specifically in clinical epidemiology, neuroepidemiology, and epidemiologic methods. He is the director of the Bordeaux International School of Population Health Sciences, a host of short courses covering topics around population health studies.
Inserm Research Center for Epidemiology and Biosatistic (U897)
University of Bordeaux Segalen
146 rue Léo Saignat - CS61292
33076 Bordeaux cedex
Tobias Kurth's principal areas of research consist of the following focuses: (i) neuroepidemiology/cardiovascular epidemiology with specific focus on the interrelationships between vascular risk factors, migraine, and cardiovascular disease as well as the prevention and consequences of stroke and Parkinson's disease; (ii) pharmacoepidemiology, specifically the risks and benefits of analgesic use and over-the-counter medications; and (iii) the application of tools to control for confounding in observational studies, particularly the propensity score.
Dr. Kurth is Co-Investigator of the US-based Women's Health Study and the Physicians' Health Study; he also works with the 3 City Study and the Epidemiology of Vascular Aging Study in France. He is Principal Investigator of projects evaluating genetic determinants of migraine and the association between restless legs syndrome and vascular disease. Additionally, he has received a Chair of Excellence from the French National Research Agency (ANR) to study associations between migraine, the vascular system, and their effects on brain function and structure.
In the framework of the call "Investments for the future" by the French government, the prospective study internet-based Student's Health Research Enterprise (i-Share) has been funded (Principal Coordinator Prof. Christophe Tzourio), for which Dr. Kurth is Co-Investigator of the entire study and Principal Investigator of the migraine domain.